Valuation AstraZeneca PLC Xetra

Stocks

Delayed Xetra 16:35:36 05/02/2026 GMT			5-day change	1st Jan Change
160.70 ^EUR	+0.59%		-.--%	+1.81%

09-18	Alexion Biologics License Application for Efzimfotase Alfa Accepted and Granted Priority Review by Us Fda for Treatment of Patients with Hypophosphatasia Aged 2 Years and Older	CI
09-18	European Stocks Close Sharply Lower in Friday Trading as Middle East Fighting Continues to Choke Oil Supply	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	259,306	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-9.9%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	279,000	271,237	262,494
Change	-	12.57%	-0.25%	-1.74%	36.64%	-10.34%	-2.78%	-3.22%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	21.3x	18.6x	16.1x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	4.8x	4.19x	3.63x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.3x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.11x	3.87x	3.65x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.42x	4.05x	3.69x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	12.6x	11.1x	9.79x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.2x	11.7x	10.3x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	29.1x	20.8x	18x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.44%	4.8%	5.57%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.334	3.538	3.647
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.99%	2.12%	2.18%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.862	9.012	10.39
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.4%	39.3%	35.1%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,120	66,976	71,119
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,175	24,340	26,800
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,092	23,268	25,554
Net income ¹	112	3,288	5,961	7,035	10,225	12,071	13,803	15,828
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	19,694	11,931	3,188
Reference price ²	117.51	135.16	135.02	131.05	185.60	167.18	167.18	167.18
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	10/02/22	09/02/23	08/02/24	06/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.78x	11.92x	24.16x	0.6%	1,028B
JOHNSON & JOHNSON	30.03x	6.68x	18.7x	1.99%	651B
ABBVIE INC.	33.38x	7.81x	16.15x	2.6%	466B
ROCHE HOLDING AG	19.33x	4.72x	11.71x	2.81%	346B
NOVARTIS AG	19.72x	5.16x	12.79x	3.11%	266B
ASTRAZENECA PLC	21.26x	4.42x	12.58x	1.99%	259B
AMGEN INC.	24.43x	6.42x	11.43x	2.62%	208B
NOVO NORDISK A/S	12.52x	4.56x	9.46x	4.01%	191B
GILEAD SCIENCES, INC.	-45.4x	6.61x	25.81x	2.19%	186B
Average	16.45x	6.48x	15.87x	2.44%	400.19B
Weighted average by Cap.	23.68x	7.73x	17.83x	1.99%